US Tech 100

19,168.00

0.52%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Transgene S.A. ADS (MM) (TRGNY)
Transgene S.A. ADS (MM) (TRGNY) News

TRGNY

Transgene . (TRGNY)

Transgene S.A. ADS (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TRGNY

1

Date	Time	Source	Headline	Symbol	Company
10/19/2005	1:00AM	PR Newswire (US)	Transgene : Cash Position and Net Cash Expenditures as of September 30, 2005	NASDAQ:TRGNY
09/21/2005	12:01AM	PR Newswire (US)	Transgene to Voluntarily Delist From Nasdaq	NASDAQ:TRGNY
08/03/2005	12:01AM	PR Newswire (US)	Transgene Announces First Half 2005 Financial Results	NASDAQ:TRGNY
07/21/2005	12:01AM	PR Newswire (US)	Transgene Announces Achievement of Clinical Milestone by Merck & Co., Inc. Using Transgene's Proprietary Technology	NASDAQ:TRGNY
07/11/2005	12:01PM	PR Newswire (US)	Transgene Raises Euro 34.9 Million	NASDAQ:TRGNY
05/20/2005	12:01AM	PR Newswire (US)	Transgene Announces 20-F Form Filing	NASDAQ:TRGNY
05/17/2005	12:01AM	PR Newswire (US)	Transgene's Therapeutic Vaccine MVA-MUC1-IL2 at ASCO:	NASDAQ:TRGNY
05/16/2005	12:01AM	PR Newswire (US)	Transgene Presents Updated Positive Phase II Data of Its Therapeutic Vaccine MVA-MUC1-IL2 In Prostate Cancer at Annual ASCO Meet	NASDAQ:TRGNY
04/26/2005	12:01AM	PR Newswire (US)	Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare Conference	NASDAQ:TRGNY
04/13/2005	12:01AM	PR Newswire (US)	Transgene: Cash Position and Net Cash Expenditures as of March 31, 2005	NASDAQ:TRGNY
04/05/2005	12:01AM	PR Newswire (US)	Transgene to Present Phase II Data of Its MVA-UC1-IL2 Cancer Vaccine at ASCO's 2005 Annual Meeting	NASDAQ:TRGNY
02/23/2005	12:00AM	PR Newswire (US)	Transgene Announces Fiscal Year 2004 Financial Results	NASDAQ:TRGNY
02/23/2005	12:00AM	PR Newswire (US)	Transgene: New Strategy in Therapeutic Vaccines, MVA-Muc1-IL2 Meets Primary Endpoint in Lung Cancer Phase II	NASDAQ:TRGNY
02/14/2005	11:01PM	PR Newswire (US)	Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific Officer	NASDAQ:TRGNY
12/07/2004	11:01PM	PR Newswire (US)	Transgene Appoints Philippe Archinard As New Chief Executive Officer	NASDAQ:TRGNY
11/30/2004	10:34AM	PR Newswire (US)	Transgene Moves Forward Its Vaccine Candidate MVA-HPV-IL2 In A Novel Approach Against Pre-Cancerous Cervical Lesions	NASDAQ:TRGNY
11/02/2004	11:01PM	PR Newswire (US)	Transgene: Cash Position and Net Cash Expenditures as of September 30, 2004	NASDAQ:TRGNY
08/04/2004	12:01AM	PR Newswire (US)	Transgene Announces Second Quarter and First Half 2004 Financial Results	NASDAQ:TRGNY
07/01/2004	8:31AM	PR Newswire (US)	Transgene Manufactures Clinical Lots of HIV Vaccine Candidates for the EUROVAC Project	NASDAQ:TRGNY
06/15/2004	1:00AM	PR Newswire (US)	Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal Health	NASDAQ:TRGNY	Transgene S.A. ADS (MM)
06/15/2004	12:01AM	PR Newswire (US)	Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal Health	NASDAQ:TRGNY
06/08/2004	12:01AM	PR Newswire (US)	Transgene Presents Data on MVA-MUC1-IL2 Cancer Vaccine at ASCO and ASGT Annual Meetings	NASDAQ:TRGNY
05/12/2004	8:45AM	PR Newswire (US)	Transgene to Present Data at 2004 ASCO Annual Meeting	NASDAQ:TRGNY
05/05/2004	12:01AM	PR Newswire (US)	Transgene Announces First Quarter 2004 Financial Results	NASDAQ:TRGNY
04/14/2004	12:01AM	PR Newswire (US)	Transgene: Data Presented at The American Association of Cancer Research Annual Meeting Suggest Significant Opportunities for An	NASDAQ:TRGNY
03/17/2004	11:01PM	PR Newswire (US)	Transgene's MVA-HPV-IL2 Vaccine Shows Activity in Phase II Clinical Trial	NASDAQ:TRGNY
02/10/2004	11:01PM	PR Newswire (US)	Transgene Announces Fourth Quarter and Fiscal Year 2003 Financial Results	NASDAQ:TRGNY
02/08/2004	11:00PM	PR Newswire (US)	Transgene Reports Positive Interim Phase II Data from MVA-Muc1-IL2 Cancer Vaccine Program	NASDAQ:TRGNY
11/04/2003	11:01PM	PR Newswire (US)	Transgene Announces Third Quarter 2003 Financial Results	NASDAQ:TRGNY
11/02/2003	11:01PM	PR Newswire (US)	Transgene Signs Pre-Clinical AIDS Vaccine Manufacturing Agreement With ANRS and INSERM	NASDAQ:TRGNY